The microcolony mode of growth in vivo — an ecological perspective

[1]  J. A. Bass,et al.  A rat model of chronic respiratory infection with Pseudomonas aeruginosa. , 2015, The American review of respiratory disease.

[2]  J. Costerton,et al.  Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection. , 1988, Journal of medical microbiology.

[3]  D. Allison,et al.  Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? , 1988, The Journal of antimicrobial chemotherapy.

[4]  J. G. Jolley,et al.  Auger electron spectroscopy and x‐ray photoelectron spectroscopy of the biocorrosion of copper by gum arabic, bacterial culture supernatant and Pseudomonas atlantica expolymer , 1988 .

[5]  D. Bruckner,et al.  Microbial contamination of contact lens care systems. , 1987, American journal of ophthalmology.

[6]  G. Pier,et al.  Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. , 1987, The New England journal of medicine.

[7]  J. Costerton,et al.  Inocula for antimicrobial sensitivity testing: a critical review. , 1987, The Journal of antimicrobial chemotherapy.

[8]  J. Costerton,et al.  Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis. , 1987, Journal of clinical & laboratory immunology.

[9]  J. Govan,et al.  Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. , 1986, Microbiological sciences.

[10]  G. Pier,et al.  Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia , 1986, Infection and immunity.

[11]  D. White.  Environmental effects testing with quantitative microbial analysis: Chemical signatures correlated with in situ biofilm analysis by FT/IR , 1986 .

[12]  A. Tomasz,et al.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. , 1986, Journal of general microbiology.

[13]  H. Colten,et al.  ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS , 1985, The Lancet.

[14]  D. Woods,et al.  Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. , 1985, The Journal of infectious diseases.

[15]  J. Nickel,et al.  Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material , 1985, Antimicrobial Agents and Chemotherapy.

[16]  Michael R. W. Brown,et al.  Outer membrane antigens of mucoid Pseudomonas aeruginosa isolated directly from the sputum of a cystic fibrosis patient , 1984 .

[17]  J. Costerton,et al.  Influence of culture conditions on expression of the mucoid mode of growth of Pseudomonas aeruginosa , 1984, Journal of clinical microbiology.

[18]  R. Cozens,et al.  Influence of nutrient limitation of growth on stability and production of virulence factors of mucoid and nonmucoid strains of Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.

[19]  R. Hancock,et al.  Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis , 1983, Infection and immunity.

[20]  B. Iglewski,et al.  Toxins of Pseudomonas aeruginosa: new perspectives. , 1983, Reviews of infectious diseases.

[21]  K. Botzenhart,et al.  Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. , 1983, The Journal of infectious diseases.

[22]  P. O. Schiøtz.  SYSTEMIC AND MUCOSAL IMMUNITY AND NON‐SPECIFIC DEFENSE MECHANISMS IN CYSTIC FIBROSIS PATIENTS , 1982 .

[23]  J. Costerton,et al.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis , 1980, Infection and immunity.

[24]  G. Geesey,et al.  Sessile bacteria: An important component of the microbial population in small mountain streams 1 , 1978 .

[25]  H. Niemann,et al.  Host capsule depolymerase activity of bacteriophage particles active on Klebsiella K20 and K24 strains. , 1974, Virology.

[26]  J. Costerton,et al.  Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.

[27]  J. G. Jolley,et al.  Auger electron spectroscopy and x-ray photoelectron spectroscopy of the biocorrosion of copper by Gum Arabic, BCS and Pseudomonas atlantica exopolymer , 1987 .

[28]  M. R. Brown,et al.  Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. , 1985, The Journal of antimicrobial chemotherapy.

[29]  M. R. Brown,et al.  The influence of environment on envelope properties affecting survival of bacteria in infections. , 1985, Annual review of microbiology.

[30]  P. Lambert,et al.  Evidence that mucoid Pseudomonas aeruginosa in the cystic fibrosis lung grows under iron-restricted conditions , 1984 .

[31]  J. Costerton,et al.  River epilithon: toward a structural-functional model , 1984 .

[32]  James D. Bryers,et al.  Early fouling biofilm formation in a turbulent flow system: Overall kinetics , 1981 .